Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 2965 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#2965, RRID:AB_2255933
- Product name
- Phospho-Akt (Thr308) (C31E5E) Rabbit mAb
- Antibody type
- Monoclonal
- Reactivity
- Human, Mouse, Rat, Hamster, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.
AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.
Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.
mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Jothi M, Nishijo K, Keller C, Mal AK
Cell cycle (Georgetown, Tex.) 2012 Mar 1;11(5):895-908
Cell cycle (Georgetown, Tex.) 2012 Mar 1;11(5):895-908
AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.
Sykes SM, Lane SW, Bullinger L, Kalaitzidis D, Yusuf R, Saez B, Ferraro F, Mercier F, Singh H, Brumme KM, Acharya SS, Scholl C, Tothova Z, Attar EC, Fröhling S, DePinho RA, Armstrong SA, Gilliland DG, Scadden DT
Cell 2011 Sep 2;146(5):697-708
Cell 2011 Sep 2;146(5):697-708
Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.
Mahajan K, Coppola D, Challa S, Fang B, Chen YA, Zhu W, Lopez AS, Koomen J, Engelman RW, Rivera C, Muraoka-Cook RS, Cheng JQ, Schönbrunn E, Sebti SM, Earp HS, Mahajan NP
PloS one 2010 Mar 19;5(3):e9646
PloS one 2010 Mar 19;5(3):e9646
mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Guertin DA, Stevens DM, Saitoh M, Kinkel S, Crosby K, Sheen JH, Mullholland DJ, Magnuson MA, Wu H, Sabatini DM
Cancer cell 2009 Feb 3;15(2):148-59
Cancer cell 2009 Feb 3;15(2):148-59
No comments: Submit comment
No validations: Submit validation data